Cooley M&A

JANUARY 20, 2022

Despite everyone’s efforts in 2021, including the rollout of vaccines and varying rounds of lockdowns and work-from-home mandates, a true “return to normal” for M&A dealmakers was foiled anew by COVID-19 and its variants. trillion during 2021 – an increase of 71% compared to 2020 – and accounted for 20% of the $5.9 trillion(!)

M&A 40

M&A Insurance Mergers and Acquisitions IPO 40

The Deal

OCTOBER 17, 2023

Direct-to-consumer businesses, darlings of the investor community in 2021, saw their techlike valuations plummet. Public markets, however, have been tepid, with the much-awaited IPO of L Catterton Management Ltd. portfolio company Birkenstock GmbH & Co.

M&A 64

M&A IPO Retail Medical 64

InvestmentBank.com

JANUARY 14, 2021

Second, the IPO market, a key exit avenue for VC investments, proved increasingly strong and resilient throughout the year. These were just a few of many strong IPOs seen this year. As of December 23rd, 2020, US stock markets saw 477 IPOs, more than doubling the 233 IPOs from 2019, at least 120 of which were venture-backed [14] [11].

Capital 40

Capital IPO S&P Hospitality 40

Mergers and Inquisitions

SEPTEMBER 11, 2024

Operating metrics and valuation multiples , especially for the assets and companies that are the most different (see below). So, even if you’re advising entire companies, you must still be familiar with asset-level modeling and valuation and how an entire portfolio works. What Do You Do as an Analyst or Associate?

Investment Banking 59

Investment Banking Banking Bank Investment 59

Mergers and Inquisitions

MARCH 13, 2024

Others would counter that growth equity’s rapid ascent was mostly due to the easy money that persisted between 2008 and 2021. This style is about purchasing minority stakes in cash-flow-negative-but-high-growth companies that want to scale and eventually go public or sell (think: Uber or Airbnb before their IPOs).

Private Equity 105

Private Equity Equities Capital Portfolio 105

Cooley M&A

JANUARY 25, 2023

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

JANUARY 22, 2021

Despite dealmaking anxieties in the first half of the year, valuations remained strong, and discount opportunities were few and far between. Creative deal terms and financing arrangements were also attractive aspects of SPAC deals as compared to their IPO cousin. 2] Global deal value in the technology sector was up 47.3%

M&A 40

M&A IPO Mergers and Acquisitions Business 40

Wall Street Mojo

JANUARY 17, 2024

Financial Modeling & Valuation Courses Bundle (25+ Hours Video Series) –>> If you want to learn Financial Modeling & Valuation professionally , then do check this ​ Financial Modeling & Valuation Course Bundle ​ ( 25+ hours of video tutorials with step by step McDonald’s Financial Model ).

Accountant 98

Accountant Finance Finance Profitability 98

Cooley M&A

JANUARY 22, 2021

Earnouts continue to be popular methods for addressing valuation uncertainty, particularly in the life sciences space. As we have previously observed , the use of milestone-based earnouts to bridge a valuation gap is often a short-term solution that presents many long-term complications. Earnouts Remain Popular – and Difficult.

M&A 40

M&A Mergers and Acquisitions Collaboration Mergers 40

The Deal

AUGUST 9, 2023

M&A is a central part of SymphonyAI’s growth strategy as the company prepares for a potential private placement and, eventually, an IPO. “We’re billion valuation in 2021. We’re not looking for technology acquisitions, because we have plenty of technology in my shop,” Dhawan said.

M&A 40

M&A Private Equity Retail Financial Services 40

Focus Investment Banking

APRIL 14, 2024

From 2018 to 2021, the total number of bakery workers declined nearly 12%, leaving operators struggling to replace highly experienced talent. Healthy competition for the top bakeries has increased valuations in recent years, with strong purchase price / cash flow (EBITDA) multiples.

M&A 52

M&A Food Private Equity Manufacturing 52

Cooley M&A

JANUARY 20, 2022

Although the COVID-19 pandemic that defined 2020 continued to shape much of the life sciences industry in 2021, the way that it did was markedly different. 2] Examples of this strategy coming to bear in 2021 included Thermo Fisher Scientific’s acquisition of PPD for $17.4 driven assets. term average of approximately 35%.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Mergers and Inquisitions

APRIL 10, 2024

This happened for a few reasons: 1) Soaring Valuations – Many sources say that sports team valuations “outperformed” the S&P 500 over the past 20 years, which is a polite way of saying that many teams are now valued at extremely high multiples. The MLB started allowing PE ownership in 2019, and the NHL followed suit in 2021.

Private Equity 103

Private Equity Equities Funds Entertainment 103

Cooley M&A

FEBRUARY 1, 2024

However, unlike the go-go era of 2021, tech deals in 2023 tended to be bolt-on rather than transformative, took longer to get done, and required more creativity and bespoke structures. Private equity activity accounted for only 27% of tech M&A in 2023, a six-year low (and a substantial decrease from the 2021 record of 36%).

M&A 59

M&A Mergers and Acquisitions Private Equity Equities 59

Cooley M&A

JANUARY 25, 2023

However, deal activity fizzled in the second half of 2022, as high inflation, aggressive anti-inflation monetary policies, geopolitical instability, assertive antitrust regulators and tightening financing markets depressed target valuations, reduced strategic acquirer confidence and sidelined private equity sponsor buyers. trillion. [2]

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Mergers and Inquisitions

NOVEMBER 20, 2024

Reference any deals you’ve worked on that required analysis of these points and talk about how they affected the valuation or client’s decisions (this is more grounded than just saying, “I like high-growth companies!”). Exits Up Slightly But Still Poor – M&A activity has ticked up modestly, but the IPO market is still mostly shut.

Private Equity 59

Private Equity Equities Capital Valuation 59

Cooley M&A

FEBRUARY 3, 2025

The tech deal floodgates still havent opened, as persistent valuation mismatches, a still (mostly) closed tech IPO market, stiff competition and worldwide regulatory scrutiny continue to weigh on activity, particularly for VC-backed exits and mega deals. billion acquisition of Altair, IBMs pending $6.4 So is tech M&A back?

M&A 59

M&A Mergers and Acquisitions Private Equity Acquisitions 59